Cultural Foundation
Author:
Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting
May 5, 2026
Verrica Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 12, 2026
May 5, 2026
Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference
April 6, 2026
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
March 11, 2026